MedPath

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

Not Applicable
Conditions
Portal Vein, Cavernous Transformation Of
Hypertension, Portal
Registration Number
NCT02504034
Lead Sponsor
Sun Yat-sen University
Brief Summary

To evaluate the values of portosystemic shunt and other interventional radiology approaches for treatment of symptomatic portal hypertension in patients with cavernous transformation of portal vein.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • All patients with portal hypertention who have enough image information to confirm cavernous transformation of portal vein.
Exclusion Criteria
  • Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Incidence Rate of Gastrointestinal Bleeding1 month

No gastrointestinal bleeding proved by patients' symptoms (If the patients had the history of gastrointestinal bleeding before)

Ascites Volume (mL)1 month

No ascites proved by CT scanning or ultrasound (If the patients had the history of ascites before)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Radiology

🇨🇳

Guangzhou, Guangdong, China

Department of Radiology
🇨🇳Guangzhou, Guangdong, China
Zaibo Jiang, MD.
Contact
+86 020 85252066
jiangzaibo@aliyun.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.